Table 1.
Background Demographic and Clinical Characteristics of Study Participants
| HIV uninfected | Primary infection | Chronic HIV CD4 ≥200 | Chronic HIV CD4 <200 | |
| Number in group | 54 | 96 | 178 | 116 |
| Sex, %male | 81% | 89.5% | 78% | 85% |
| Age, y | 44.5a | 36.0 | 36.0 | 37.5 |
| (40–50) | (30–46) | (30–46) | (32–45) | |
| CD4+ T Cells (cells/μL) | 836b | 575b | 421b | 66b |
| (674–1013) | (412–730) | (300–536) | (28–135) | |
| CD8+ T Cells (cells/μL) | 464c | 994d | 1051c | 597c |
| (329–634) | (692–1426) | (735–1357) | (395–805) |
NOTE. Values shown are medians (interquartile ranges) except where noted. Significant differences between groups corrected for post hoc analysis (P < .013) are noted:
a
Significantly different from all other groups.
b
Each group comparison significant.
c
Different from primary infection and chronic HIV CD4 ≥ 200 groups.
d
Different from HIV uninfected and chronic HIV <200 groups.